Menopause HRT hormone replacement therapy medicines, Lenzetto estradiol spray and progesterone capsules, in a woman's bedroom at home.

Menopause hormone replacement therapy (HRT) medicines on a bedroom windowsill, with Lenzetto 1.53mg oestradiol transdermal spray in its brown and white carton, Dr Reddy's progesterone 100mg soft capsules and an Estée Lauder perfume bottle containing golden fragrance. Patterned fabric, mottled window glass and greenery outside frame the products in a domestic setting, reflecting how prescribed hormone treatment becomes part of everyday life for middle-aged women. Lenzetto delivers oestrogen through the skin to relieve menopausal symptoms. Progesterone is commonly prescribed alongside systemic oestrogen for women with a womb to protect the uterine lining. Treatment can help manage hot flushes, night sweats and disrupted sleep during perimenopause and postmenopause. Dose selection and medicine combinations require individual clinical advice. The image is relevant to renewed UK news coverage of HRT supply and women's access to effective treatment in October 2026. On 12 October, a government medicine supply notification reported FemSeven Conti patches out of stock until late November; continuing Estradot patch disruptions also attracted national headlines. These shortages concern particular patch products, rather than a confirmed shortage of the Lenzetto spray or progesterone capsules pictured. On 22 October 2026, peers questioned the Government in the House of Lords about HRT availability, supply-chain resilience, GP prescribing, affordability and unequal access. Health minister Baroness Merron said three of 70 UK HRT products were affected and outlined alternative supplies and pharmacy shortage protocols. NHS figures for 2025/26 show two million women aged 40 and over receiving HRT prescriptions in England, with substantial geographical and deprivation-related variations. The photograph links a personal menopause treatment routine to public debate over dependable NHS prescribing, medicine availability and women's health.